IGC Pharma, Inc. SEC filings IGC
IGC Pharma, Inc. has 818 filings in SEC EDGAR's recent list, going back to May 13, 2005. Its latest annual report, Form 10-KT, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 22, 2026 | — |
| DEF 14A | Proxy statement | Oct 22, 2026 | Dec 2, 2026 |
| DEFA14A | Additional proxy material | Aug 19, 2025 | — |
| DEF 14A | Proxy statement | Aug 18, 2025 | Oct 10, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 4, 2025 | Oct 10, 2025 |
| DEFA14A | Additional proxy material | Jul 9, 2024 | — |
| DEF 14A | Proxy statement | Jul 8, 2024 | Aug 23, 2024 |
| DEF 14A | Proxy statement | Jul 26, 2023 | Aug 18, 2023 |
| DEF 14A | Proxy statement | Jul 25, 2022 | Sep 9, 2022 |
| DEF 14A | Proxy statement | Sep 15, 2021 | Oct 15, 2021 |
| DEFA14A | Additional proxy material | Dec 22, 2020 | — |
| DEF 14A | Proxy statement | Dec 8, 2020 | Jan 11, 2021 |
| DEF 14A | Proxy statement | Dec 13, 2019 | Jan 7, 2020 |
| DEF 14A | Proxy statement | Jul 6, 2018 | Aug 6, 2018 |
| DEF 14A | Proxy statement | Oct 10, 2017 | Nov 8, 2017 |
| PRE 14A | Preliminary proxy statement | Sep 15, 2017 | Sep 15, 2017 |
| PRE 14A | Preliminary proxy statement | Mar 8, 2017 | Mar 31, 2017 |
| DEF 14A | Proxy statement | Jul 24, 2015 | Aug 25, 2015 |
| DEF 14A | Proxy statement | Aug 4, 2014 | Aug 25, 2014 |
| PRE 14A | Preliminary proxy statement | Jul 25, 2014 | Jul 25, 2014 |
| DEF 14A | Proxy statement | Sep 4, 2013 | Sep 30, 2013 |
| DEF 14A | Proxy statement | Aug 2, 2012 | Sep 7, 2012 |
| DEF 14A | Proxy statement | Dec 9, 2011 | Dec 28, 2011 |
| PRE 14A | Preliminary proxy statement | Nov 25, 2011 | Nov 25, 2011 |
| DEF 14A | Proxy statement | Aug 1, 2011 | Aug 25, 2011 |
| PRE 14A | Preliminary proxy statement | Jul 21, 2011 | Jul 21, 2011 |
| DEF 14A | Proxy statement | Jul 23, 2010 | Aug 16, 2010 |
| DEF 14A | Proxy statement | Jun 25, 2008 | Jul 15, 2008 |
| PRE 14A | Preliminary proxy statement | Jun 3, 2008 | Jun 3, 2008 |
| DEFA14A | Additional proxy material | Feb 29, 2008 | — |
| DEF 14A | Proxy statement | Feb 8, 2008 | Feb 20, 2008 |
| DEFA14A | Additional proxy material | Jan 29, 2008 | — |
| PRE 14A | Preliminary proxy statement | Jan 9, 2008 | Jan 9, 2008 |
| PREM14A | Filing | Nov 23, 2007 | Nov 23, 2007 |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IGC (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- MD
- Headquarters
- Potomac, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1326205
- Former names
- India Globalization Capital, Inc. (until Mar 21, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.